Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai Xiao Fang Pharmaceutical Co Days Payable?
Shanghai Xiao Fang Pharmaceutical CoSHSE:603207 +1.72%38 Days Payable is 63.55 as of Mar. 2026, which is 21% above its 10-year median of 52.67. GuruFocus rates SHSE:603207 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 926 Drug Manufacturers companies, Shanghai Xiao Fang Pharmaceutical Co ranks worse than 66.31% on this metric.
SHSE:603207's Days Payable is ranked worse than 66.31% of 926
companies
in the Drug Manufacturers industry
Industry Median: 90.22
vs SHSE:603207: 62.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xiao Fang Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Xiao Fang Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Xiao Fang Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Xiao Fang Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai Xiao Fang Pharmaceutical Co's Days Payable falls into.
Shanghai Xiao Fang Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a Days Payable of 63.55 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. This is 21% above median its historical median of 52.67. Over the past decade, Shanghai Xiao Fang Pharmaceutical Co's Days Payable has ranged from 42.94 to 62.28. According to the industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #614 out of 926 companies in the Drug Manufacturers industry, placing it in the top 66.3%.
Is Shanghai Xiao Fang Pharmaceutical Co's Days Payable too high?
Shanghai Xiao Fang Pharmaceutical Co's current Days Payable of 63.55 is 21% above median its 10-year median of 52.67. Over the past 10 years, this metric has ranged from a low of 42.94 to a high of 62.28. The Drug Manufacturers industry median Days Payable is 90.22. Shanghai Xiao Fang Pharmaceutical Co's value of 63.55 is 29.6% below this industry median. Based on the distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #614 out of 926 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Shanghai Xiao Fang Pharmaceutical Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xiao Fang Pharmaceutical Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #614 out of 926 companies for Days Payable. This places Shanghai Xiao Fang Pharmaceutical Co in the lower half of its industry. The industry median Days Payable is 90.22. Shanghai Xiao Fang Pharmaceutical Co's value of 63.55 is 29.6% below this benchmark. Historically, Shanghai Xiao Fang Pharmaceutical Co's own Days Payable has ranged from 42.94 to 62.28 over the past decade. While the company's 10-year median is 52.67 vs. the industry median of 90.22, Shanghai Xiao Fang Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Xiao Fang Pharmaceutical Co's current Days Payable of 63.55 is 29.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Xiao Fang Pharmaceutical Co's current Days Payable is 63.55, which is 21% above median its own 10-year median of 52.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xiao Fang Pharmaceutical Co stock overvalued right now?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a current Days Payable of 63.55. The current Days Payable is 63.55, which is 21% above median its 10-year median of 52.67 and 29.6% below the Drug Manufacturers industry median of 90.22. Shanghai Xiao Fang Pharmaceutical Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207), the current Days Payable is 63.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanghai Xiao Fang Pharmaceutical Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603207 has been successfully added to your 
